Industry Trend Analysis - A Recap On The Pharmaceuticals & Healthcare Outlook For 2017: Central & Eastern Europe - AUG 2017

BMI View: The sustainable expansion of healthcare access will continue to shape the CEE pharmaceuticals market in 2017. There will be a greater focus on cross-border communication and collaboration within the pharmaceutical sphere, in order to negotiate lower prices for medicines, improve and harmonise pharmaceutical policy and reduce barriers to trade. In addition, there will be a concerted effort to advance legislation in response to the challenges posed by the increasing demand for higher quality medicines while economic constraints remain.

At the end of 2016, we set out a number of expectations for the year ahead in our annual review of the Central and Eastern Europe (CEE) pharmaceuticals and healthcare sector ( see ' Pharmaceuticals & Healthcare Outlook For 2017: Central & Eastern Europe ' , November 23 2016). We have selected the two key trends and reviewed the progress of each. This article notes our views and details any developments that support or confirm our outlook. Overall, we expect that these views will continue to play out.

Sub-Regional Cooperation

This article is part of our Western Europe coverage. To access this article subscribe now or sign up for free trial